Researchers zero in on therapeutic target for aggressive uterine cancer
A team of scientists led by the University of Michigan Health Rogel Cancer Center has found that a class of U.S. Food and Drug Administration-approved drugs can effectively stop a highly aggressive type of uterine cancer ...
Dec 17, 2021
0
17
